Lehrstuhl für Corporate Finance

Fischer, M., Rilke, R., Yurtoglu, B. (2023), When, and why, do teams benefit from self-selection?, Experimental Economics, Vol. 26 (4), pp. 749–774.

Black, B., De Carvalho, A. G., Kim, W., Yurtoglu, B. (2023), How useful are commercial corporate governance ratings? Evidence from emerging markets, Journal of Corporate Finance, Vol. 80, 102405.

Yurtoglu, B., Naumer, H.-J. (2022), It is not only what you say, but how you say it: ESG, corporate news and the impact on CDS spreads, Global Finance Journal, Vol. 52, 100571.

Maier, F., Yurtoglu, B. (2022), Board characteristics and the insolvency risk of non-financial firms, Journal of Risk and Financial Management, Vol. 15 (7), 303.

Aktas, N., Boone, A., Witkowski, A., Xu, G., Yurtoglu, B. (2021), The role of internal M&A teams in takeovers, Review of Finance, Vol. 25 (4), pp. 1047–1088.

Ararat, M., Yurtoglu, B. (2021), Female directors, board committees, and firm performance: time-series evidence from Turkey, Emerging Markets Review, Vol. 48, 100768.

Ararat, M., Claessens, S., Yurtoglu, B. (2021), Corporate governance in emerging markets: a selective review and an agenda for future research, Emerging Markets Review, Vol. 48, 100767.

Karaevli, A., Yurtoglu, B. (2021), Family ownership, market development, and internationalization of Turkish business groups (1925-2017), Journal of World Business, Vol. 56 (6), 101264.

Black, B., Gledson De Carvalho, A., Khanna, V., Kim, W., Yurtoglu, B. (2020), Which aspects of corporate governance do and do not matter in emerging markets, Journal of Law, Finance, and Accounting, Vol. 5 (1), pp. 137-177.

Mahlich, J., Yurtoglu, B. (2019), Returns on different types of investment in the global pharmaceutical industry, Managerial and Decision Economics, Vol. 40 (1), pp. 16-36.